Mativ (MATV) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
23 Dec, 2025Executive summary
SaaS/SAS segment delivered strong Q4 and 2024 results, with sales pipeline over 50% larger than last year and robust momentum across all categories.
FAM segment faced challenges from sluggish industrial demand and late-2023 paint protection film quality issues, but quality has improved and turnaround efforts are underway.
Over $20 million in overhead costs were removed in 2024, with further cost reductions and operational streamlining planned.
Portfolio repositioned through divestitures, debt reduced by over 35%, and plant footprint streamlined by over 25% in the last 18 months.
Q4 2024 sales rose 1.4% year-over-year to $458.6M; GAAP net income was $1.5M, reversing a $13.6M loss last year.
Financial highlights
Consolidated net sales for the quarter were $459 million, up 4.3% organically and 1.4% as reported year-over-year.
Adjusted EBITDA from continuing operations was $44.8 million, down 10% from the prior year, impacted by higher input and manufacturing costs.
SaaS/SAS net sales reached $291 million, up almost 13% organically and 8% as reported, with adjusted EBITDA of $36 million, up nearly 8% year-over-year.
FAM net sales were $168 million, down over 7% year-over-year, with adjusted EBITDA of $26 million, down more than $10 million.
Net debt at quarter/year-end was $995 million, with available liquidity of $451 million and a net leverage ratio of 4.4x.
Outlook and guidance
Q1 2025 expected to be impacted by higher inventory and input costs, with pricing actions planned to offset these over the year.
Full-year 2025 focus on profit growth, cash generation, margin improvement, and aggressive cost reductions.
Capital expenditures planned at $50 million, with one-time costs of $15–$20 million and a normalized tax rate of 24%.
Raw material headwinds of $10–$15 million expected in the first half of 2025, to be offset by pricing.
Improvements in FAM segment expected in the second half of 2025 as turnaround activities progress.
Latest events from Mativ
- Operational transformation and targeted investments drive growth and margin expansion.MATV
Investor presentation25 Mar 2026 - Annual meeting to vote on directors, auditor, compensation, and equity plan amendment.MATV
Proxy Filing17 Mar 2026 - Proxy covers director elections, auditor ratification, compensation, and equity plan amendment.MATV
Proxy Filing17 Mar 2026 - Record free cash flow and EBITDA gains achieved despite market headwinds and goodwill impairment.MATV
Q4 202519 Feb 2026 - Adjusted EBITDA rose 13% year-over-year, with margin and cash flow improvements in Q2 2024.MATV
Q2 20242 Feb 2026 - Adjusted EBITDA up 10% on flat sales; SAS growth offsets FAM headwinds amid restructuring.MATV
Q3 202416 Jan 2026 - All proposals passed, including director election and equity plan amendment; no questions raised.MATV
AGM 202523 Dec 2025 - Board recommends voting FOR all proposals, with focus on governance, compensation, and ESG.MATV
Proxy Filing2 Dec 2025 - Annual meeting to vote on director election, auditor ratification, pay, and equity plan.MATV
Proxy Filing2 Dec 2025